Marla Angermeier, MD
Dermatology · Providence, RINPI 1477618064
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $246 of the $306 with a category attached, or 80.4%. 7 manufacturers reported payments, led by Ortho Dermatologics, A Division Of Bausch Health US, LLC at 21.4% of the total. Reporting peaked in 2019 at $270 and has fallen 95.1% since, to $13 in 2023. That places this record below the midpoint for dermatology clinicians in RI, where the typical reported total is $1,463.
Across 14 payments — averaging $21.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$66
- Merz North America, Inc.$62
- LEO Pharma Inc.$60
- AbbVie$48
- Prugen, Inc. Pharmaceuticals$32
- Pfizer$25
- plus $15 from 1 others
What the payments were for
- Food & beverage$24680%
- Education$6020%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $66 |
| Merz North America, Inc. | 4 | $62 |
| LEO Pharma Inc. | 2 | $60 |
| AbbVie | 3 | $48 |
| Prugen, Inc. Pharmaceuticals | 1 | $32 |
| Pfizer | 2 | $25 |
| Dermira, Inc. | 1 | $15 |
How this compares
$306 in reported general payments places this provider in the 40th percentile of 61 dermatology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 110 | $5,621 |
| ValacyclovirValacyclovir Hcl | 91 | $2,797 |
| Tretinoin | 33 | $1,778 |
| Doxycycline Hyclate | 91 | $1,503 |
| Imiquimod | 22 | $1,403 |
| Betamethasone Dipropionate | 31 | $1,204 |
| Clobetasol Propionate | 22 | $1,000 |
| Tacrolimus | 11 | $983 |
| Ciclopirox | 24 | $939 |
| CiclopiroxCiclopirox Olamine | 29 | $498 |
| Doxycycline Monohydrate | 18 | $478 |
| Ketoconazole | 26 | $378 |
| Mupirocin | 35 | $268 |
| Minocycline Hcl | 15 | $264 |
| Triamcinolone Acetonide | 42 | $236 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Providence
- Helena KuhnProvidence$63K
- Martin WeinstockProvidence$62K
- Farah MoustafaProvidence$51K
- Abrar QureshiProvidence$38K
- Scott HammermanProvidence$9K
- Laura della TorreProvidence$9K
- Benjamin KahnProvidence$4K
- Rachel HoffmannProvidence$4K
- Jennie MugliaProvidence$2K
- Daniella ReimannProvidence$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.